Skip to main content
SpringerLink
Log in

Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

The present study, based upon the retrospective evaluation of 352 patients with primary myelodysplastic syndrome (pMDS), revealed hypoplastic MDS in 42 patients (11.9%). Median age is similar in hypo- and normo-/hypercellular MDS (72.6 versus 70.7 versus 72.4 years). Hypoplastic MDS occurred significantly more often in women compared with normo- and hypercellular MDS. Sequential biopsies were performed in 14 patients, showing a persistence of hypoplasia over a period of up to 43 months. The proportion of patients showing mesenchymal reaction, especially an increase of mast cells, was significantly higher in hypoplastic MDS, whereas dysplastic features of hematopoiesis occurred less frequently and were of lower grade in comparison to normo-/hyperplastic MDS. Among the subgroup with hypoplastic bone marrow, the classification according to FAB criteria revealed 28 patients with RA (66.7%), three with RARS (7.1%), and eight with RAEB (19.0%), as well as one patient each with RAEB-T and CMMol (2.4% each), and one case which had to be reckoned among the category of unclassifiable MDS (2.4%). Median survival was 21.8 months for hypoplastic MDS, 26.9 months for normoplastic MDS, and 14.2 months for hyperplastic MDS. During follow-up, 14 patients (33%) with hypoplastic MDS developed acute nonlymphatic leukemia. Although not a constant finding, karyotype abnormalities involving particularly chromosome 7 seem to be associated with hypoplastic MDS. The results confirm the existence of a hypoplastic variant of MDS which seems to more frequently affect female patients, and which requires bone marrow biopsy for its accurate diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Appelbaum FR, Storb R, Ramberg RE, Shulman HM, Buckner CD, Clift RA, Deeg HJ, Fefer A, Sanders J, Self St, Singer J, Stewart P, Sullivan K, Witherspoon R, Thomas ED (1987) Treatment of preleukemic syndromes with marrow transplantation. Blood 69: 92–96

    PubMed  Google Scholar 

  2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukemias. Br J Haematol 33: 451–458

    PubMed  Google Scholar 

  3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C, and the French-American-British (FAB) Co-operative Group (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 189–199

    PubMed  Google Scholar 

  4. Bennett JM (1986) Classification of the myelodysplastic syndromes. Clin Haematol 15: 909–923

    Google Scholar 

  5. Coiffier B, Adeleine P, Viala JJ, Byron PA, Fiere D, Gentilhomme O, Vuvan H (1983) Dysmyelopoietic syndromes. A search for prognostic factors in 193 patients. Cancer 52: 8390

    Google Scholar 

  6. Cutler SJ, Ederer F (1958) Maximum utilization of the life table in analyzing survival. J Chronic Dis 55: 699–712

    Google Scholar 

  7. Damashek W (1967) Riddle: What do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and “hypoplastic” leukemia have in common? Blood 30: 251–254

    PubMed  Google Scholar 

  8. Delacrétaz F, Schmidt PM, Piguet D, Bachmann F, Costa J (1987) Histopathology of myelodysplastic syndromes. Am J Clin Pathol 87: 180–186

    PubMed  Google Scholar 

  9. Dezza L, Cazzola M, Bergamaschi G, Burgio VL, Stella CC, Fenoglio C, Ghizza A, Nalli G, Sacchi F, Ascari E (1983) Myelodysplastic syndrome with monosomy 7 in adulthood: A distinct preleukaemic disorder. Haematologica (Pavia) 68: 723

    Google Scholar 

  10. Fohlmeister I, Fischer R, Mödder B, Riester M, Schaefer HE (1985) Aplastic anemia and the hypocellular myelodysplastic syndrome: histomorphological, diagnostic and prognostic features. J Clin Pathol 38: 1218–1224

    PubMed  Google Scholar 

  11. Georgii A, Vykoupil KF, Buhr T, Choritz H, Döhler U, Kaloutsi V, Werner M (1990) Chronic myeloproliferative disorders in bone marrow biopsies. Pathol Res Pract 186: 3–27

    PubMed  Google Scholar 

  12. Harnden DG, Klinger HP (eds) (1985) An international system for human cytogenetic nomenclature. Karger, Basel

    Google Scholar 

  13. Kerkhofs H, Hermans J, Haak HL, Leeksma CHW (1987) Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br J Haematol 65: 73–81

    PubMed  Google Scholar 

  14. Kitagawa M, Kamiyama R, Takemura T, Kasuga T (1989) Bone marrow analysis of the myelodysplastic syndromes: histological and immuno-histological features related to the evolution of overt leukemia. Virchows Arch [B] 57: 47–53

    Google Scholar 

  15. Mangi MH, Mufti GH (1992) Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies. Blood 79: 198–205

    PubMed  Google Scholar 

  16. Maschek H, Georgii A, Kaloutsi V, Werner M, Bandecar K, Kressel MG, Choritz H, Freund M, Hufnagl D (1992) Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients. Eur J Haematol 48: 208–214

    PubMed  Google Scholar 

  17. Motoji T, Teramura M, Takahashi M, Oshimi K, Okada M, Kusakabe K, Mizoguchi H (1990) Successful treatment of refractory anemia with high-dose methyl-prednisolone. Am J Hematol 33: 8–12

    PubMed  Google Scholar 

  18. Nand S, Godwin JE (1988) Hypoplastic myeloplastic syndrome. Cancer 62: 958–964

    PubMed  Google Scholar 

  19. Planque MM de, Kluin-Nelemans HC, van Krieken JHJM, Kluin PhM, Brand A, Beverstock GC, Willemze R, van Rood JJ (1988) Evolution of acquired severe aplastic anemia to myelodysplasia and subsequent leukaemia in adults. Br J Haematol 70: 55–62

    PubMed  Google Scholar 

  20. Planque MM de, van Krieken JHJM, Kluin-Nelemans HC, Colla LPJM, van der Burgh F, Brand A, Kluin PM (1989) Bone marrow histopathology of patients with severe aplastic anaemia before treatment and at follow-up. Br J Haematol 72: 439–444

    PubMed  Google Scholar 

  21. Rios A, Canizo MC, Sanz MA, Vallespi T, Sanz G, Torrabadella M, Gomis F, Ruiz C, San Miguel JF (1990) Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors. Br J Haematol 75: 26–33

    PubMed  Google Scholar 

  22. Sanz GF, Sanz MA, Vallespi T, Canizo MC, Sanz G, Torrabadella M, Garcia C, Irriguible D, San Miguel JF (1989) Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 74: 395–408

    PubMed  Google Scholar 

  23. Tomonaga M, Tomonaga Y, Kusano M, Ichimaru M (1984) Sequential karyotypic evolutions and bone marrow aplasia preceding acute myelomonocytic transformation from myelodysplastic syndrome. Br J Haematol 58: 53–60

    PubMed  Google Scholar 

  24. Tricot G, De Wolf-Peeters C, Hendrickx B, Verwilghen RL (1984) Bone marrow histology in myelodysplastic syndromes. I. Histological findings in myelodysplastic syndromes and comparison with bone marrow smears. Br J Haematol 57: 423–430

    PubMed  Google Scholar 

  25. Vallespi T, Torrabadello M, Julia A, Irriguible D, Jaen A, Acebedo G, Triginer J (1985) Myelodysplastic syndromes: a study of 101 cases according to the FAB classification. Br J Haematol 61: 83–92

    PubMed  Google Scholar 

  26. Vykoupil K-F, Thiele J, Georgii A (1976) Histochemical and immunohistochemical techniques on acrylate embedded bone biopsy. Blut 32: 215–218

    PubMed  Google Scholar 

  27. Weide M van der, Sizoo W, Nauta JJP, Krefft J, Langenhuijsen MMAC (1988) Myelodysplastic syndromes: analysis of clinical and prognostic features in 96 patients. Eur J Haematol 41: 115–122

    PubMed  Google Scholar 

  28. Yoshida Y, Oguma H, Maekawa T (1988) Refractory myelodysplastic anaemias with hypocellular bone marrow. J Clin Pathol 41: 763–767

    PubMed  Google Scholar 

  29. Young NS (1992) The problem of clonality in aplastic anemia: Dr. Damashek's riddle, restated. Blood 79: 1385–1392

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pathologisches Institut, Medizinische Hochschule Hannover, W-3000, Hannover 61, Germany

    H. Maschek, V. Kaloutsi, M. Rodriguez-Kaiser, M. Werner, H. Choritz & A. Georgii

  2. II. Medizinische Abteilung, Allgemeines Krankenhaus Altona, W-2000, Hamburg 50, Germany

    K. Mainzer

  3. I. Medizinische Klinik, Technische Universität München, W-8000, München 80, Germany

    M. Dietzfelbinger

Authors
  1. H. Maschek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V. Kaloutsi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Rodriguez-Kaiser
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Werner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Choritz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Mainzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Dietzfelbinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Georgii
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by grants from theDeutsche Krebshilfe, Bonn, Germany

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maschek, H., Kaloutsi, V., Rodriguez-Kaiser, M. et al. Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis. Ann Hematol 66, 117–122 (1993). https://doi.org/10.1007/BF01697619

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01697619

Key words

Search

Navigation